Margaret Hamburg

Last updated
Peter Brown
​
(m. 1992)​
Peggy Hamburg
Margaret-Hamburg Headshot.jpg
Hamburg in 2015
21st Commissioner of Food and Drugs
In office
May 22, 2009 –April 3, 2015
Relatives Beatrix Hamburg (Mother)
David A. Hamburg (Father)
Education Harvard University (BA, MD)

Margaret Ann "Peggy" Hamburg (born July 12, 1955, Chicago, Illinois) is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) [3] and co-chair of the InterAcademy Partnership (IAP). [4] She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015. [5]

Contents

Early life and education

Hamburg is the daughter of Beatrix Hamburg and David A. Hamburg, both physicians. Her mother was the first self-identified African-American woman to be accepted at Vassar College [6] and to earn a degree from the Yale University School of Medicine. [7] Her father is President Emeritus of the Carnegie Corporation of New York and also served as the president of the AAAS in 1984. [8] [9]

Hamburg graduated from Harvard College in 1977 and earned her M.D. from Harvard Medical School in 1983. [10] She completed her medical residency training at the New York Hospital-Cornell Medical Center and is Board Certified in Internal Medicine.

Hamburg is married to Peter Fitzhugh Brown, a computer scientist and artificial intelligence expert. The couple were married on May 23, 1992. [11] Brown is the chief executive officer of Renaissance Technologies. [12] Renaissance Technologies employees were collectively the top donors to President Donald Trump's 2016 campaign [13] and collectively the third largest donors to Hillary Clinton, [14] giving $15.5 million and $16.5 million respectively. The couple has two children together.

Hamburg was ranked on the list of The World's 100 Most Powerful Women three times—ranking 21st in 2011, 61st in 2012, and 59th in 2013. [15]

Career

Following her medical training, Hamburg moved to Washington, D.C., to begin her career in public service. She served in several roles, beginning with a position in the Office of Disease Prevention and Health Promotion at the US Department of Health and Human Services. [16] She also worked as a clinical instructor for Georgetown University School of Medicine from 1986 to 1990. [17]

From May 1989 to May 1990, she worked as assistant director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health under Anthony Fauci. In this position, she participated in HIV/AIDS policy development and research. [18]

In 1991 Hamburg was appointed Commissioner of the New York City Department of Health and Mental Hygiene, where she served for six years, working first for Mayor David Dinkins and then-Mayor Rudy Giuliani. During her tenure, she worked on improved services for women and children, a needle-exchange program to reduce HIV transmission, a program to curtail the resurgence and spread of tuberculosis, and the nation's first public health bioterrorism preparedness program. [19]

In 1997, President Bill Clinton appointed Hamburg as Assistant Secretary for Planning and Evaluation at the U.S. Department of Health and Human Services. She served in this policy role until 2001 when she became the founding Vice President for Biological Programs and later the Senior Scientist for the Nuclear Threat Initiative, [20] a foundation created by Ted Turner dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. In that role, Hamburg spearheaded efforts to prevent, detect, and respond to both naturally occurring and deliberately caused biological threats. She worked on reforms to reduce the dangers associated with modern bioterrorism and infectious diseases such as pandemic influenza.

In June 2001, Hamburg participated in the Operation Dark Winter exercise at Andrews Air Force Base simulating a bioterrorism event involving weaponized smallpox. [21]

Hamburg is a member of the Medical Advisory Team for the Sidwell Friends School, where she also served on the board of trustees from 2004 to 2009. [22] On July 13, 2005, she was announced as an advisor to the Project on Emerging Nanotechnologies by the Pew Charitable Trusts and Woodrow Wilson International Center for Scholars. [23]

U.S. Food and Drug Administration

Hamburg (center right) visits a California rice farm in 2013 while Commissioner of the FDA FDA's Rice Tour- Looking for Insights on Arsenic (0860) (9684318485).jpg
Hamburg (center right) visits a California rice farm in 2013 while Commissioner of the FDA

Hamburg was nominated by President Barack Obama in March 2009 to become Commissioner of the Food and Drug Administration, [24] and was unanimously confirmed in May 2009. [25] As FDA Commissioner she was known for advancing regulatory science, streamlining and modernizing FDA's regulatory pathways, and globalization of the agency, as well as the implementation of the Family Smoking Prevention and Tobacco Control Act (2009), the Food Safety Modernization Act (2011), and a review of the system for the evaluation and approval of medical devices.

Hamburg was the longest-serving FDA commissioner since David A. Kessler, as well as the second woman to hold the position. [26] She served at the FDA until her resignation on March 28, 2015. [27] [28] [29] [19]

During Hamburg's tenure at the FDA, the agency was criticized for speeding approvals at the expense of safety, while some industry voices indicated the pace was "justified". The FDA, under Hamburg's leadership approved 51 drugs in 2014 alone, which was noted as being "most in more than 20 years" to which Hamburg attributes to "innovative approaches". [29]

National Academy of Medicine

In April 2015 Hamburg was appointed Foreign Secretary of the National Academy of Medicine. [30] In December 2016, Hamburg was named president-elect for the American Association for the Advancement of Science. [31] She served a three-year term as an officer and member of the executive committee of the AAAS Board of Directors beginning in February 2017.

In 2018, she participated in the Clade X pandemic exercise that modelled a fictional parainfluenza bioterrorism attack designed to reduce the global population. [32] [33] She played the role of Secretary of Health and Human Services. [34] The event was held by the Johns Hopkins Center for Health Security. [35] Hamburg joined the board of directors for Alnylam Pharmaceuticals in 2018. [36]

In 2020, Hamburg participated in the strategic framework development for the Grand Challenge on Climate Change, Human Health, & Equity. Other notable participants included Peter Daszak of EcoHealth Alliance, Jeremy Farrar of Wellcome Trust, and representatives from the National Institutes of Health, Rockefeller Foundation, London School of Hygiene & Tropical Medicine, ExxonMobil, University of Hong Kong, Burroughs Wellcome Fund, World Health Organization, African Development Bank, Robert Wood Johnson Foundation, National Oceanic and Atmospheric Administration, and numerous universities. [37]

Additionally, Hamburg was appointed by the Council on Foreign Relations to serve on its Independent Task Force on Improving Pandemic Preparedness, co-chaired by Sylvia Mathews Burwell and Frances Fragos Townsend. [38] That year, she also served on the CSIS-LSHTM High-Level Panel [39] on Vaccine Confidence and Misinformation amid the COVID-19 pandemic, co-chaired by Heidi Larson and J. Stephen Morrison. [40]

Hamburg participated in a tabletop exercise at the March 2021 Munich Security Conference modelling a fictional international outbreak of monkeypox. [41] The exercise was led by the Nuclear Threat Initiative and funded by Open Philanthropy. [42] In the exercise scenario, the hypothetical outbreak was set to begin on May 15, 2022. On May 18, 2022, a real confirmed case of monkeypox was reported in an American traveller who had recently travelled to Canada. [43]

Awards and recognition

Margaret A. Hamburg at Spotlight Health, Aspen Ideas Festival, in 2015. Margaret A. Hamburg at Spotlight Health Aspen Ideas Festival 2015.JPG
Margaret A. Hamburg at Spotlight Health, Aspen Ideas Festival, in 2015.

Hamburg is a Fellow of the American Association for the Advancement of Science and the American College of Physicians, as well as a member of the Council on Foreign Relations and the National Academy of Medicine, where she now serves as Foreign Secretary.

Hamburg has received numerous awards, among them the National Consumers League's Trumpeter Award in 2011 [44] and the National Center for Health Research's 2011 Health Research Policy Hero Award. [45] She has also received the American College of Clinical Pharmacology's (ACCP) Nathaniel T. Kwit Memorial Distinguished Service Award, [46] the New York Academy of Medicine Medal for Distinguished Contributions in Health Policy, [47] the Radcliffe Alumnae Award and the American Lung Association's Breath of Life Award. Hamburg was the 2017 recipient of the FDAAA's Harvey W. Wiley Lecture Award for Outstanding Leadership in Advancing Public Health.

She is a distinguished senior fellow with the Center for Strategic and International Studies [48] and holds several Honorary Degrees.

Forbes named her as one of the world's 100 most powerful women multiple times, most recently in 2014 (#51). [49]

In 2022, Hamburg was awarded the AAAS Philip Hauge Abelson Prize which honors individuals' groundbreaking work in the areas of public service, scientific achievement or notable services to community. [26]

Other activities

Corporate boards

Non-profit organizations

Hamburg formerly served on the boards of the Rockefeller Foundation, the Rockefeller University, the Nathan Cummings Foundation, Conservation International and Henry Schein Inc. She has participated as a member of the Central Intelligence Agency's Intelligence Science Board. [69]

She is also a member of the National Advisory Council for the COVID Collaborative. [70]

Hamburg is affiliated with the World Economic Forum. [71] On April 6, 2021, she participated as a speaker at a WEF event titled "The Next Frontier: Synthetic Biology". [72]

In 2016, Hamburg, her husband, Johnson & Johnson, and others were named in a lawsuit by Larry Klayman, who has since been suspended from practicing law in DC. The suit was dismissed with prejudice in 2017 by a District of Columbia federal judge. [73]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Amgen</span> American multinational biopharmaceutical company

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.

<span class="mw-page-title-main">Michael Osterholm</span> American epidemiologist

Michael Thomas Osterholm is an American epidemiologist, Regents Professor at the University of Minnesota School of Public Health, and director of the Center for Infectious Disease Research and Policy at the University of Minnesota.

<span class="mw-page-title-main">Paul Offit</span> American pediatric immunologist

Paul Allan Offit is an American pediatrician specializing in infectious diseases, vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine. Offit is the Maurice R. Hilleman Professor of Vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, former chief of the Division of Infectious Diseases (1992–2014), and the director of the Vaccine Education Center at the Children's Hospital of Philadelphia.

<span class="mw-page-title-main">Leonard A. Cole</span> American academic (1933–2022)

Leonard Aaron Cole, was an American dentist, political scientist and expert on bioterrorism and terror medicine. He was adjunct professor of political science at Rutgers University-Newark, New Jersey and of emergency medicine at the Rutgers New Jersey Medical School. A pioneer in developing the field of terror medicine, he was founding director of the Program on Terror Medicine and Security at the medical school.

<span class="mw-page-title-main">Stephen Hahn</span> American physician (born 1960)

Stephen Michael Hahn is an American physician who served as the commissioner of food and drugs from 2019 to 2021. Before becoming commissioner, he was an oncologist serving as chief medical executive of the MD Anderson Cancer Center. In 2021, he became chief medical officer at Flagship Pioneering, the venture capital firm that launched Moderna.

Jane L. Delgado is a Cuban-American clinical psychologist, health care advocate, non-profit executive, and author. She is president and CEO of the National Alliance for Hispanic Health. She is the author of The Buena Salud Guide book series and The Latina Guide to Health. In 2012 the series was acquired by William Morrow an Imprint of HarperCollins Publishers and published "Buena Salud Guide to Arthritis and Your Life."

<span class="mw-page-title-main">Maria Freire</span> American health executive

Maria C. Freire is a Peruvian-American biophysicist who was the president and executive director of the Foundation for the National Institutes of Health (FNIH) from 2012-2021. She also is a member of the U.S. National Academy of Medicine and Council on Foreign Relations. Freire works in global health, technology commercialization and intellectual property management, focusing on the discovery, development and access to medical interventions.

The Reagan-Udall Foundation for the Food and Drug Administration is a private nonprofit (501c3) organization, created to support the mission of the U.S. Food and Drug Administration (FDA) to help equip FDA staff with the highest caliber, regulatory science and technology in order to enhance the safety and effectiveness of FDA regulated products. Although it was mandated by Congress in the Food and Drug Administration Amendments Act of 2007 to help support and promote FDA's regulatory science priorities, it is independent of the agency, with its own Board of Directors, staff and research agenda. The Reagan-Udall Foundation creates public–private partnerships to advance research in regulatory science, enhance medical decision making, and promote innovation. It also advances regulatory science through fellowships and other training programs, both for private scientists and for FDA staff.

David Allen Hamburg was an American psychiatrist. He served as president of the Carnegie Corporation of New York from 1982 to 1997. He also served as the President of the Institute of Medicine, National Academy of Sciences and president of the American Association for the Advancement of Science. He had also been a member of the National Academy of Sciences since 1998. He was also a member of the American Academy of Arts and Sciences and the American Philosophical Society. He had previously been chair of the department of psychiatry at Stanford. His wife, Beatrix Hamburg, followed a similarly successful career path. Their daughter, Margaret Hamburg, is a physician who has followed their footsteps into public service becoming Commissioner of the Food and Drug Administration in 2009. His son, Eric Hamburg, is an author, attorney and film producer in Los Angeles.

Beatrix Ann Hamburg was an American psychiatrist whose long career in academic medicine advanced the field of child and adolescent psychiatry. Hamburg was the first known African-American to attend Vassar College, and was also the first African-American woman to attend Yale Medical School. Hamburg held professorships at Stanford, Harvard, Mt. Sinai and—most recently—at Weill Cornell Medical College. She was on the President's Commission on Mental Health under President Jimmy Carter. Hamburg was a president of the William T. Grant Foundation, and also directed the child psychiatry divisions at Stanford University and Mount Sinai. She originally was going to go into pediatric medicine, but instead found herself interested in psychiatry. She researched early adolescence, peer counseling, and diabetic children and adolescents. She was a member of the National Academy of Medicine and a fellow of the American Association for the Advancement of Science. She received a Foremother Award for her lifetime of accomplishments from the National Research Center for Women & Families in 2012.

Biosecurity in the United States is governed by the Bureau of Western Hemisphere Affairs, which is part of the US Department of State. It obtains guidance and advice on specific matters relating to biosecurity from various other government agencies.

<span class="mw-page-title-main">Brett Giroir</span> American physician-scientist (born 1960)

Brett P. Giroir is an American pediatrician. He was formerly the U.S. assistant secretary for health, a four-star admiral in the U.S. Public Health Service Commissioned Corps and an acting Food and Drug Administration commissioner.

<span class="mw-page-title-main">Luciana Borio</span> Brazilian-American physician and public health administrator

Luciana Borio is a Brazilian-American infectious disease physician and public health administrator. She is a vice president at In-Q-Tel. She previously served as director for Medical and Biodefense Preparedness at the National Security Council, acting chief scientist of the U.S. Food and Drug Administration (FDA), assistant commissioner for counterterrorism policy of the FDA, and director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials, the development of medical countermeasures for health emergencies, and the public health responses to Ebola and Zika outbreaks.

<span class="mw-page-title-main">Robert Califf</span> American cardiologist (born 1951)

Robert McKinnon Califf is an American cardiologist who currently serves as the 25th Commissioner of the Food and Drug Administration.

Paula J. Olsiewski is an American biochemist who is a Contributing Scholar at the Johns Hopkins Center for Health Security. She was a Program Director at the Alfred P. Sloan Foundation, where she created and directed the Foundation's programs in the Microbiology of the Built Environment, the Chemistry of Indoor Environments and Civic Initiatives. She directed the Biosecurity program until its conclusion in 2011 and the Synthetic Biology program until its conclusion in 2014.

<span class="mw-page-title-main">Scott Gottlieb</span> American physician and government administrator (born 1972)

Scott Gottlieb is an American physician, investor, and author who served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc and gene sequencing company Illumina, Inc., and a contributor to the cable financial news network CNBC and the CBS News program Face the Nation. An elected member of the National Academy of Medicine, Gottlieb is the author of The New York Times best selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed. His forthcoming book, The Miracle Century: Making Sense of the Cell Therapy Revolution, traces the scientific achievements that propelled progress in cell therapies.

<span class="mw-page-title-main">Patisiran</span> Pharmaceutical drug

Patisiran, sold under the brand name Onpattro, is a medication used for the treatment of polyneuropathy in people with hereditary transthyretin-mediated amyloidosis, a fatal rare disease that is estimated to affect 50,000 people worldwide.

Delese Mimi Darko is a Ghanaian pharmacist. In 2017, she became the first woman to be appointed chief executive officer of the Ghana Food and Drugs Authority by Nana Akuffo-Addo.

<span class="mw-page-title-main">Michelle McMurry-Heath</span> American Immunologist

Michelle McMurry-Heath is a medical doctor, immunologist, and from June 2020 until October 2022 served as chief executive officer for the Biotechnology Innovation Organization (BIO).

John Maraganore is an American scientist, entrepreneur, and life sciences industry leader.

References

  1. ↑ "PN530 - Nomination of Margaret Ann Hamburg for Department of Health and Human Services, 105th Congress (1997-1998)". www.congress.gov. 30 October 1997.
  2. ↑ "PN249 - Nomination of Piyush Jindal for Department of Health and Human Services, 107th Congress (2001-2002)". www.congress.gov. 25 May 2001.
  3. ↑ "Organization and Governance". American Association for the Advancement of Science. Retrieved 2019-04-16.
  4. ↑ Partnership (IAP), the InterAcademy (17 April 2019). "World's science academies gather in Korea to elect new chairs, welcome new members, and stand up for sustainable development". www.interacademies.org. Retrieved 2022-04-21.
  5. ↑ FDA head Margaret Hamburg to resign in March; Ostroff to be acting chief (Washington Post article-February 5, 2015)
  6. ↑ Streett, Laura (February 11, 2014). "Vassar's First Black Students". The Gargoyle Bulletin. Vassar College . Retrieved April 23, 2016.
  7. ↑ Peart, Karen N. (May 27, 2011). "School of Medicine honors its first African-American women graduates". Yale News. Yale University . Retrieved April 23, 2016.
  8. ↑ "New AAAS President Emphasizes Science as Public Service". AAAS. 2018-02-22. Retrieved 2018-09-05.
  9. ↑ Lederberg, Joshua (1983-07-29). "David A. Hamburg: President-Elect of AAAS". Science. 221 (4609): 431–432. Bibcode:1983Sci...221..431L. doi: 10.1126/science.221.4609.431 . ISSN   0036-8075. PMID   17755464.
  10. ↑ "Margaret Hamburg | University of Washington - Department of Global Health". globalhealth.washington.edu. Retrieved 2022-04-04.
  11. ↑ "AllGov - Officials". www.allgov.com. Retrieved 2022-04-04.
  12. ↑ Patterson, Scott; Strasburg, Jenny (16 March 2010). "Pioneering Fund Stages Second Act". Wall Street Journal. Retrieved 19 December 2017.
  13. ↑ "Top Contributors, federal election data for Donald Trump, 2016 cycle". Open Secrets. Retrieved 19 December 2017.
  14. ↑ "Top Contributors, federal election data for Hillary Clinton, 2016 cycle". Open Secrets. Retrieved 19 December 2017.
  15. ↑ "Margaret a Hamburg, American Association for the Advancement of Science: Profile and Biography". www.bloomberg.com. Retrieved 2022-04-04.
  16. ↑ "Changing the Face of Medicine | Dr. Margaret Hamburg". National Library of Medicine . Archived from the original on 2009-03-25. Retrieved 2022-07-18.{{cite web}}: CS1 maint: unfit URL (link)
  17. ↑ Wallechinsky, David (2016). "Hamburg, Margaret". AllGov - Officials. Archived from the original on 2022-07-18. Retrieved 2022-07-18.
  18. ↑ "Margaret Hamburg". Broad Institute . 2021-06-07. Archived from the original on 2022-05-27. Retrieved 2022-07-18.
  19. 1 2 "Biography of Margaret A. Hamburg, M.D." U.S. Food & Drug Administration.
  20. ↑ Pugh, Tony (5 February 2015). "FDA commissioner Margaret Hamburg to step down in March". McClatchy DC. McClatchy Washington Bureau. Retrieved 19 September 2016.
  21. ↑ "Dark Winter". Johns Hopkins Center for Health Security . Archived from the original on 2022-05-28. Retrieved 2022-05-28.
  22. ↑ "Medical Advisory Team". Sidwell Friends . Archived from the original on 2022-06-02. Retrieved 2022-07-18.
  23. ↑ "Pew Charitable Trusts, Wilson Center Launch Project on Emerging Nanotechnologies". Project on Emerging Nanotechnologies . 2005-07-13. Archived from the original on 2022-07-18. Retrieved 2022-07-18.
  24. ↑ Gardiner Harris (11 March 2009). "Ex-New York Health Commissioner Is F.D.A. Pick". The New York Times. Retrieved 2009-03-12.
  25. ↑ Gratzer, David (2009-05-21). "FDA commissioner". US FDA. Retrieved 2010-09-12.
  26. 1 2 "Margaret A. Hamburg Wins 2022 AAAS Abelson Prize | American Association for the Advancement of Science". www.aaas.org. Retrieved 2022-04-04.
  27. ↑ Dennis, Brady (2015-02-05). "FDA head Margaret Hamburg to resign in March". Washington Post. ISSN   0190-8286 . Retrieved 2022-04-04.
  28. ↑ "FDA Commissioner Margaret Hamburg To Resign in March, Writes Farewell Letter to FDA Colleagues". Policy & Medicine. Retrieved 2022-04-04.
  29. 1 2 Tavernise, Sabrina (2015-02-05). "F.D.A. Commissioner Leaving After Six Years of Breakneck Changes". The New York Times. ISSN   0362-4331 . Retrieved 2022-04-04.
  30. ↑ "Margaret A. Hamburg Appointed as Institute of Medicine Foreign Secretary". nationalacademies.org. The National Academies of Sciences, Engineering, and Medicine. April 6, 2015. Retrieved April 23, 2016.
  31. ↑ Korte, Andrea. "Margaret Hamburg Selected to Serve as AAAS President-Elect". AAAS. Retrieved 9 January 2017.
  32. ↑ Alexopulos, Nick (2018-05-15). "Clade X policy recommendations". Johns Hopkins Center for Health Security . Archived from the original on 2021-04-14. Retrieved 2022-05-28.
  33. ↑ "Clade X Slides" (PDF). Johns Hopkins Center for Health Security . 2018. Archived (PDF) from the original on 2022-01-13. Retrieved 2022-05-28.
  34. ↑ Cizek, Julia. "Bio of Margaret Hamburg, playing the role of Sec. of HHS | Clade X". Johns Hopkins Center for Health Security . Archived from the original on 2022-05-31. Retrieved 2022-05-31.
  35. ↑ Watson, Crystal; Toner, Eric S.; Shearer, Matthew P.; Rivers, Caitlin; Meyer, Diane; Hurtado, Christopher; Watson, Matthew; Gronvall, Gigi Kwik; Adalja, Amesh A.; Sell, Tara Kirk; Inglesby, Tom (2019-10-01). "Clade X: A Pandemic Exercise". Health Security. 17 (5): 410–417. doi:10.1089/hs.2019.0097. ISSN   2326-5094. PMID   31593508. S2CID   203984655.
  36. ↑ "The Alnylam® Leadership Team". Alnylam Pharmaceuticals . Archived from the original on 2022-05-27. Retrieved 2022-07-18.
  37. ↑ "Climate Change Planning Committee". National Academy of Medicine . Archived from the original on 2022-05-29. Retrieved 2022-05-29.
  38. ↑ Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19 Council on Foreign Relations, October 2020.
  39. ↑ "Former FDA commissioner Margaret Hamburg named in massive conspiracy and racketeering lawsuit involving Johnson & Johnson, a Wall Street hedge fund, and the Levaquin drug – Crescent City Times.com" . Retrieved 2022-04-04.
  40. ↑ Call to Action: CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation, October 19, 2020 Center for Strategic and International Studies (CSIS).
  41. ↑ "Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats". Nuclear Threat Initiative . Archived from the original on 2022-05-26. Retrieved 2022-05-28.
  42. ↑ "Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats" (PDF). Nuclear Threat Initiative . November 2021. Archived (PDF) from the original on 2022-05-27. Retrieved 2022-05-28.
  43. ↑ Reilly, Patrick (2022-05-18). "First case of monkeypox confirmed in US this year in man who had traveled to Canada". New York Post . Archived from the original on 2022-05-19. Retrieved 2022-05-28.
  44. ↑ "2011 Trumpeter Recipient: Dr. Margaret Hamburg". 4 October 2011. Retrieved 11 March 2015.
  45. ↑ "2011 Foremothers & Health Policy Hero Awards". National Research Center for Women & Families. Archived from the original on 14 May 2011. Retrieved 19 November 2012.
  46. ↑ "2016 ACCP Annual Meeting". American College of Clinical Pharmacology.
  47. ↑ "The Academy Medal for Distinguished Contributions in Health Policy". The New York Academy of Medicine.
  48. ↑ Office of Research on Women's Health (25 March 2004). "Dr. Margaret Hamburg". Changing the Face of Medicine. National Institutes of Health. Retrieved 2009-03-06.
  49. ↑ "The World's 100 Most Powerful Women". Forbes. Retrieved 26 June 2014.
  50. ↑ Leadership Alnylam Pharmaceuticals.
  51. ↑ "Board of Trustees". American Museum of Natural History. Retrieved 19 September 2016.
  52. ↑ "Leadership". amfAR, The Foundation for AIDS Research . 2008. Archived from the original on 2008-04-16. Retrieved 2022-07-18.
  53. ↑ "Scientific Advisory Committee". Bill & Melinda Gates Foundation. Retrieved 19 September 2016.
  54. ↑ "Dr. Margaret A. Hamburg". Bipartisan Commission on Biodefense . Archived from the original on 2022-05-29. Retrieved 2022-07-18.
  55. ↑ "Board of Directors". Broad Institute . 2021. Archived from the original on 2021-11-01. Retrieved 2022-07-18.
  56. ↑ CSIS Announces Commission on Strengthening America’s Health Security Center for Strategic and International Studies (CSIS), press release of October 2, 2017.
  57. ↑ Members of the Commission on Strengthening America’s Health Security Center for Strategic and International Studies (CSIS).
  58. ↑ "CEPI Developments". GloPID-R. Archived from the original on 2022-05-27. Retrieved 2022-05-27.
  59. ↑ CEPI Board membership updates Coalition for Epidemic Preparedness Innovations (CEPI), press release of 5 April 2023.
  60. ↑ "Margaret A. Hamburg, M.D., Elected to Commonwealth Fund Board of Directors". The Commonwealth Fund. 31 July 2015.
  61. ↑ "CoRE Advisory Board". Duke-NUS Medical School . Archived from the original on 2022-05-28. Retrieved 2022-05-28.
  62. ↑ External Advisory Board: Margaret Hamburg Department of Global Health, University of Washington.
  63. ↑ Board members GAVI Alliance
  64. ↑ "Harvard Medical School Board of Fellows". Harvard Medical School. Retrieved 19 September 2016.
  65. ↑ Board of Directors Nuclear Threat Initiative (NTI).
  66. ↑ Scientific Advisory Board for the Autism Research Initiative: Margaret Hamburg Simons Foundation.
  67. ↑ "Board of Trustees". Urban Institute. 2017-10-25. Archived from the original on 2016-09-25. Retrieved 2016-09-19.
  68. ↑ "Vaccines and Drug-resistant Infections Strategic Advisory Board". Wellcome Trust . Archived from the original on 2020-09-30. Retrieved 2022-05-28.
  69. ↑ "Countering the Threat of Radiological Weapons". Center for American Progress . 2005-07-27. Archived from the original on 2022-06-01. Retrieved 2022-06-02.
  70. ↑ "About". COVID Collaborative. Archived from the original on 2022-05-15. Retrieved 2022-06-01.
  71. ↑ "Margaret A. Hamburg". World Economic Forum . Archived from the original on 2022-05-22. Retrieved 2022-05-28.
  72. ↑ "The Next Frontier: Synthetic Biology". World Economic Forum . 2021-04-06. Archived from the original on 2021-04-28. Retrieved 2022-05-28.
  73. ↑ "Levaquin RICO Lawsuit Dismissed By Judge In District Of Columbia - Lexis Legal News". www.lexislegalnews.com. Retrieved 2022-04-04.
Government offices
Preceded by Health Commissioner of New York City
1991–1997		Succeeded by
Benjamin Mojica
Preceded by Assistant Secretary of Health and Human Services for Planning and Evaluation
1997–2001		Succeeded by
Preceded by Commissioner of Food and Drugs
2009–2015		Succeeded by
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.